In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Novocure enters $150mm loan financing; pays off existing debt

Executive Summary

Novocure Ltd. (developed the Tumor Treating Fields alternating electrical field technology to treat cancer) entered into a $150mm non-dilutive term loan with BioPharma Credit PLC (managed by Pharmakon Advisors). The company drew down the loan in full immediately, and will use the proceeds to repay obligations under a 2015 $100mm loan agreement with Pharmakon's BioPharma Secured Investments
Deal Industry
  • Medical Devices
    • Radiofrequency Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement

Related Companies